The briefing
Inside Precision Medicine spotlights five emerging companies advancing epigenetics-based diagnostics. Using DNA methylation, fragmentomics, and related biomarkers, they are pushing liquid biopsy and cancer detection as sequencing and computing improve.
Original headline
Beyond the Genome: Five Emerging Leaders in Epigenetics Diagnostics